WallStreetZenWallStreetZen

How to Buy Gain Therapeutics Stock

Gain Therapeutics Inc

Gain Therapeutics, Inc. , a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders.

Gain Therapeutics stock last closed at $3.03, down 1.3% from the previous day, and has decreased 41.05% in one year. It has underperformed other stocks in the Biotechnology industry by 0.19 percentage points. Gain Therapeutics stock is currently +51.5% from its 52-week low of $2.00, and -46.37% from its 52-week high of $5.65.

There are currently 16.22M GANX shares outstanding. The market value of GANX is $49.15M. In the past 24 hours, 178,990 GANX shares were traded.

How to Buy Gain Therapeutics Stock

Not sure how to invest in Gain Therapeutics stock? Here's how.
  1. Decide where to buy Gain Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Gain Therapeutics stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Choose your payment method and add your info.
  4. Research Gain Therapeutics stock: The Gain Therapeutics ticker symbol is GANX. Is Gain Therapeutics stock a good investment? Should you buy shares of GANX? How do GANX's underlying business fundamentals look? Do top analysts think Gain Therapeutics is a good buy? Why has GANX's stock price moved recently? (Hint: Our stock analysis website can help you figure out if GANX is a good stock to buy).
  5. Make your GANX buy order: Decide if you will purchase GANX shares at the current market price or use a limit order to purchase GANX stock at a specific price.
  6. Get the latest news on your GANX investment: Create a watchlist to important updates regarding your position in Gain Therapeutics shares.

Step 1: Decide where to buy Gain Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy GANX stock.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world markets: From Technology to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've picked your brokerage, the next step is to fill out some personal details so you can invest in GANX stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new trading account.
  1. Submit your details by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've filled out your info on the best app for stock investing, your next step is to transfer the money for your investment:

Watch the walkthrough below if you need help transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Gain Therapeutics stock

Once you have decided on the best place to buy Gain Therapeutics stock, it's important to research their stock before you buy, so you truly understand the risk and upside.

Gain Therapeutics quick stats

GANX Price
$3.03
1w %
-4.72%
1y %
-41.05%
5y %
N/A
P/E
-1.77x
P/B
3.91x
P/S
757.5x
PEG
N/A
Revenue
$55.18k
Earnings
-$22.27M
Fore. Rev. Growth
36.39%
Fore. Earn. Growth
N/A
Market Cap
$49.15M
Next Earnings
May 10, 2024
Next Dividend
N/A

Fundamentals of GANX

WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on GANX's stock page.

How is GANX stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge GANX's fair value.

Using relative valuations measures:

  • GANX may be undervalued based on its P/B ratio of 3.91x, relative to Biotechnology industry P/B ratio of 5.85x

You can do more valuation analysis on GANX's stock here.

GANX Financial Overview

Signs that GANX is financially healthy:

  • There are more short-term assets than short-term liabilities on the GANX balance sheet.
  • There are more short-term assets than long-term liabilities on the GANX balance sheet.

Signs that GANX is not financially healthy:

  • GANX has $16.79M in cash and short term investments. This is not enough to cover its annual cash burn of $18.88M.
  • GANX has a relatively high debt to equity ratio of 0.48.
  • GANX profit margin has gone down from -12,555.1% to -40,354.3% in the past year.
  • GANX has cash burn of 18881231. It does not have sufficient cash and short-term investments to cover this.

Do Wall Street analysts think it's a good time to buy Gain Therapeutics stock

Out of 3 Equities analysts who monitor GANX, the consensus analyst rating on GANX is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Gain Therapeutics stock forecast page.

GANX Trading Indicators

SMA10
3.16
SMA20
3.36
SMA50
3.99
SMA100
3.7
SMA200
3.51
MACD
-0.24
MACD Signal
-0.25
MACD Histogram
0.01
RSI
32.74
Stochastic %K
24.03
Stochastic %D
29.35
StochRSI %K
49.53
StochRSI %D
61

GANX Earnings

Last year, GANX revenue was $55.18k. In the last five year, GANX's revenue has grown by 21.77% per year. This was slower than the Biotechnology industry average of 28.56%.

You can analyze GANX's earnings and revenue performance here.

Latest Insiders Trades at GANX

In the last year, executives and large shareholders at GANX have bought more shares than they have sold.

Jeffrey Scott Riley, Director of GANX, was the latest GANX insider to buy. They bought $115,770.00 worth of GANX stock on Mar 28, 2024.

Research more about who owns GANX shares here.

Can I rely on GANX as an income stream?

No, Gain Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about GANX

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Make your GANX buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at an exact price, use a limit order.

Click the Open button and your broker will place your order.

If you want additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest news on your GANX investment

Now that you own some GANX shares, you'll want to stay up-to-date on your new shares.

Start a watchlist to track your GANX stock.

GANX Feed

How to Buy Stock in Gain Therapeutics

To summarize, here are the 6 steps to buy stock in Gain Therapeutics:

  1. Decide where to buy Gain Therapeutics stock
  2. Sign up for a brokerage account
  3. Fund your brokerage account
  4. Research Gain Therapeutics stock
  5. Make your GANX buy order
  6. Get the latest news on your GANX investment

If you require a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to track your investment in Gain Therapeutics, create your watchlist below.

NASDAQ: GANX
$3.03-0.04 (-1.3%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: GANX
$3.03-0.04 (-1.3%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Gain Therapeutics share?

As of Apr 26, 2024, it costs $3.03 to buy one share of Gain Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.33 shares of GANX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Gain Therapeutics stock?

According to 3 Wall Street analysts who monitor Gain Therapeutics, their consensus recommendation is to buy Gain Therapeutics stock.

What is the best way to buy Gain Therapeutics stock?

One way to place an order for Gain Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.